ロード中...
Targeting the PI3K/AKT/mTOR Pathway in Hormone Positive Breast Cancer
Approximately 70% of invasive breast cancers have some degree of dependence on the estrogen hormone for cell proliferation and growth. These tumors have estrogen and/or progresterone receptors (ER/PR+), or generally referred to as hormone receptor positive (HR+) tumors, as indicated by the presence...
保存先:
| 出版年: | Drugs |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572750/ https://ncbi.nlm.nih.gov/pubmed/32894420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01394-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|